JANUARY, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
CHEMICAL APPARATUS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,343,442 | Microfluidic device and methods of using same | Fluidigm Corporation | 1-Jan-13 | United States |
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,361,754 | Recombinant reverse transcriptases | Applied Biosystems, LLC | 29-Jan-13 | United States |
8,357,516 | Primer set for amplification of UGT1A1 gene, reagent for amplification of UGT1A1 gene containing the same, and the uses thereof | ARKRAY, Inc | 22-Jan-13 | Japan |
8,361,721 | Methods for detecting, diagnosing and treating human renal cell carcinoma | Board of Regents, The University of Texas System | 29-Jan-13 | United States |
8,361,787 | Method for expression of small RNA molecules within a cell | California Institute of Technology | 29-Jan-13 | United States |
8,343,734 | Mutant of the proB gene from coryneform bacteria | Evonik Degussa GmbH | 1-Jan-13 | Germany |
8,361,792 | Random homozygous gene perturbation to enhance antibody production | Functional Genetics, Inc. | 29-Jan-13 | United States |
8,357,486 | Methods and compositions for detection of bacteria and treatment of diseases and disorders | Genelux Corporation | 22-Jan-13 | United States |
8,343,721 | Methods and kits for nucleic acid amplification | Genisphere, LLC | 1-Jan-13 | United States |
8,354,248 | Promoter-encoding DNA fragment, recombinant vector, recombiant transformant, and uses thereof | Japan Agency for Marine-Earth Science and Technology | 15-Jan-13 | Japan |
8,343,736 | Xylitol producing microorganism introduced with arabinose metabolic pathway and production method of xylitol using the same | Korea Advanced Institute of Science and Technology | 1-Jan-13 | Korea |
8,349,559 | System and method for identifying erythropoietin-responsive genes | Maine Medical Center | 8-Jan-13 | United States |
8,357,501 | Tissue protective erythropoietin receptor (NEPOR) and methods of use | Molecular Health GmbH | 22-Jan-13 | Germany |
8,361,774 | Recombinant type II restriction endonuclease, NmeAIII, and a process for producing the same | New England Biolabs, Inc. | 29-Jan-13 | United States |
8,357,666 | Reprogramming a cell by inducing a pluripotent gene through RNA interference | Nupotential, Inc. | 22-Jan-13 | United States |
8,343,765 | Gene injection apparatus and gene injection method | Olympus Corporation | 1-Jan-13 | Japan |
8,361,728 | Method for diagnosis of glutamate dehydrogenase disorders | Plaitakis; Andreas | 29-Jan-13 | Greece |
8,349,607 | Gene silencing | Plant Bioscience Limited | 8-Jan-13 | United Kingdom |
8,354,230 | Multiplex detection assay for influenza and RSV viruses | Quest Diagnostics Investments Inc. | 15-Jan-13 | United States |
8,354,246 | Non-MCCJ25-related lariat-peptide inhibitors of bacterial RNA polymerase | Rutgers, The State University of New Jersey | 15-Jan-13 | United States |
8,357,517 | Genetic analyses predictive of asthma | The Brigham and Women's Hospital, Inc. | 22-Jan-13 | United States |
8,349,557 | Compositions and methods for diagnosis of autophagic vacuolar myopathy | The Hospital for Sick Children | 8-Jan-13 | United States |
8,361,764 | Genes and enzymes for degradation of ferulic acid crosslinks | The United States of America, as represented by the Secretary of Agriculture | 29-Jan-13 | United States |
8,354,268 | Protein glycosylation modification in methylotrophic yeast | VIB, VZW | 15-Jan-13 | Belgium |
8,349,602 | Biodetectors targeted to specific ligands | Xenogen Corporation | 8-Jan-13 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,364,665 | Directional expression-based scientific information knowledge management | NextBio | 29-Jan-13 | United States |
8,352,194 | Method to identify cancer fusion genes | University of South Florida | 8-Jan-13 | United States |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,354,390 | Compositions and methods for inhibiting expression of a gene from the ebola virus | Alnylam Pharmaceuticals, Inc. | 15-Jan-13 | United States |
8,361,474 | Anti-IL-12 antibody based vectors, host cells, and methods of production and uses | Centocor, Inc. | 29-Jan-13 | United States |
8,354,101 | Pullulanase variants with increased productivity | Danisco US Inc. | 15-Jan-13 | United States |
8,349,809 | Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression | Dicerna Pharmaceuticals, Inc. | 8-Jan-13 | United States |
8,343,509 | Methods and compositions for detection of bacteria and treatment of diseases and disorders | Genelux Corporation | 1-Jan-13 | United States |
8,361,985 | Short hairpin RNA for gene knockdown of NR1 subunit of the N-methyl-D-aspartate receptor and its application on pharmaceutics | I-Shou University | 29-Jan-13 | Taiwan |
8,349,807 | Method of immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma and method for producing monoclonal antibody | Joe Chiba | 8-Jan-13 | United States |
8,343,940 | Method for enhancing chemical sensitivity or radiosensitivity of cancer cells by inhibiting expression of TSPYL5 | Korea Atomic Energy Research Institute | 1-Jan-13 | Korea |
8,354,386 | Pharmaceutical composition for treating malignant tumors containing human p31 genes | Korea Institute of Radiological & Medical Sciences | 15-Jan-13 | Korea |
8,349,808 | Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity | Medical Diagnostic Laboratories, LLC | 8-Jan-13 | United States |
8,349,308 | Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof | Mersana Therapeutics, Inc. | 8-Jan-13 | United States |
8,354,113 | Gene expressing a bifidobacterium surface-presented fusion protein | Morishita Jintan Co., Ltd. | 15-Jan-13 | Japan |
8,349,364 | Nucleic acid coated particles suitable for temporary storage | Powderject Research Limited | 8-Jan-13 | United Kingdom |
8,354,389 | miRNA-regulated differentiation-dependent self-deleting cassette | Regeneron Pharmaceuticals, Inc | 15-Jan-13 | United States |
8,361,456 | Method of inducing differentiation of bone marrow stromal cells to neural precursor cells, neural precursor cells, and uses thereof | SanBio, Inc. | 29-Jan-13 | United States |
8,362,073 | Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals | Sanofi | 29-Jan-13 | France |
8,357,369 | Genetic markers for predicting responsiveness to combination therapy | University of Southern California | 22-Jan-13 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,344,208 | Highly efficient suppressor-dependent protein expression in plants with a viral vector | Baylor University | 1-Jan-13 | United States |
8,350,124 | Root Specific expression promoter from Capsicum annuum aquaporin gene and uses thereof | Joung; Young Hee | 8-Jan-13 | Korea |
8,350,118 | Allergic disease model animals | Keio University | 8-Jan-13 | Japan |
8,357,832 | F1B-TMIR plasmid vector and transgenic mouse | National Health Research Institutes | 22-Jan-13 | Taiwan |
8,350,125 | Method for producing yellow flower by controlling flavonoid synthetic pathway | Suntory Holdings Limited | 8-Jan-13 | Japan |
8,357,837 | Fertility restoration for ogura cytoplasmic male sterile Brassica and method | Syngenta Participations AG | 22-Jan-13 | Switzerland |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,350,009 | Antibodies and related molecules that bind to 161P2F10B proteins | Agensys, Inc. | 8-Jan-13 | United States |
8,350,011 | Antibodies to ErbB2 | MedImmune Limited | 8-Jan-13 | United Kingdom |
8,344,104 | Screening systems utilizing RTP801 | Quark Pharmaceuticals, Inc. | 1-Jan-13 | United States |
8,344,105 | Polypeptides having DNA polymerase activity | Takara Bio Inc. | 1-Jan-13 | Japan |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,362,223 | Hemopoietin receptor protein, NR10 | Chugai Seiyaku Kabushiki Kaisha | 29-Jan-13 | Japan |
8,357,670 | Oligomeric compounds for the modulation of HIF-1A expression | Enzon Pharmaceuticals, Inc. | 22-Jan-13 | United States |
8,349,555 | Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures | Glinsky; Gennadi V | 8-Jan-13 | United States |
8,362,231 | RNA interference mediating small RNA molecules | Max-Planck-Gesellschaft zur Foderung der Wissenschaften E.V. | 29-Jan-13 | Germany |
8,362,224 | Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases | The Trustees of the University of Pennsylvania | 29-Jan-13 | United States |
8,361,981 | Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides | The University of British Columbia | 29-Jan-13 | Canada |
8,344,122 | Fertility restorer gene and fertility restoration method for CW-type male sterile cytoplasm of rice | Tohoku University | 1-Jan-13 | Japan |
RADIANT ENERGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,344,333 | Multi-color fluorescence enhancement from a photonic crystal surface | The Board of Trustees of the University of Illinois | 1-Jan-13 | United States |
SURGERY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,346,356 | Method for preparing an implantable controlled gene or protein delivery device | Cardiac Pacemakers, Inc. | 1-Jan-13 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.